MASHA uses mathematical modelling, computer simulation and data analysis to understand infectious disease dynamics and evaluate strategies for disease prevention and control. Working alongside public health partners, including national programmes and Ministries of Health, we translate research and surveillance data into strategic evidence to inform policy, programme planning and funding decisions.
Below is a list of projects where MASHA is or has been involved:
- Consortium for Leadership of Epidemiological-economic Analysis for epidemic Response in Africa - CLEAR-Africa (2025–2030)
Climate-focused Analytics and Modelling for Mosquito-borne Infections in Southern Africa - CAMMISA (2025–2030)
Integrated Environmental Surveillance Implementation in South Africa (2025–2026)
Global Leaders Network (GLN) for Modelling Women, Children and Adolescent Health in Eleven Countries (2024–2027)
- Measles Rubella Risk Communication Platform (2024)
- Responsible Access to Data for Analysis and Research - Health RADAR (2023–2027)
- Malaria Modelling and Analytics: Leaders in Africa - MMALA (2022–2025)
- Developing an epidemiological-macroeconomic model for South Africa (2022–2023)
- Supporting decision-making for COVID-19 in South Africa (2022–2023)
- Capacity Building in Malaria Modelling in Southern Africa (2022)
- Modelling Diphtheria – Tetanus – Pertussis vaccination in LMIC (2021–2024)
- Using mathematical modelling to optimising COVID-19 vaccination priority populations in South Africa - OPTIVAX-SA (2021–2023)
- Modelling the impact of increased testing of Syphilis in South Africa (2021–2022)
- Investment Case for the elimination of malaria in the Guyana Shield (2020)
- Developing a district-level model for the spread of COVID-19 in South Africa (2020)
- Supporting decision-making for COVID-19 in Mozambique (2020)
- Supporting decision-making for COVID-19 in Namibia (2020)
- Developing model applications to support national malaria elimination strategy design in Africa (2019–2022)
- Enhanced modelling for NMCP Decision-making in the GMS to Accelerate Malaria Elimination - ENGAME (2019–2021)
- Technical, operational, and financial feasibility of malaria elimination in Papua New Guinea, Solomon Islands, Timor-Leste, and Vanuatu (2019)
- Estimating the Risk of Declining Funding for Malaria in Ghana (2019)
- Evidence-Based Vaccinology: Is there Evidence to Introduce Routine Hepatitis A Vaccination in South Africa? (2018–2022)
- Investment Case for the elimination of malaria in South Africa (2018)
- Effect of vaccination strategy on the burden of pertussis in South Africa: A modelling proposal (2017–2020)
- Economic-epidemiological models to support malaria elimination in the Greater Mekong Sub-Region (2016 - 2018)
- Malaria Elimination Transmission and Costing in the Asia-Pacific - METCAP (2016–2017)